Skip to contentC
Cumberland Pharmaceuticals Inc
C
CPIXCumberland Pharmaceuticals Inc Q2 2019 · 10-Q
Revenue$6.94M$6.94Mno prior Q2 2018 on file Net Income-$1.95M-$1.95Mno prior Q2 2018 on file EPS Diluted-$0.13-$0.13no prior Q2 2018 on file Operating Income-$3,196,436— The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 13, 2019 · 44 d after period end